Live Breaking News & Updates on Laboratories Stock Down

Stay updated with breaking news from Laboratories stock down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Fort Sheridan Advisors LLC Has $1.39 Million Stock Position in Abbott Laboratories (NYSE:ABT)

Fort Sheridan Advisors LLC grew its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 3.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 12,584 shares of the healthcare product maker’s stock after purchasing an additional 402 shares during the quarter. Fort Sheridan Advisors […] ....

Roberte Funck , Raymond James , Lisad Earnhardt , Berger Financial Group Inc , Abbott Laboratories , Alliance Wealth Advisors , Exchange Commission , Rappaport Reiches Capital Management , Royal Bank , Fort Sheridan Advisors , Goldman Sachs Group , Renaissance Investment Group , Securities Exchange Commission , Free Report , Sheridan Advisors , Wealth Advisors , Reiches Capital Management , Financial Group Inc , Investment Group , Laboratories Stock Down , Get Free Report , Established Pharmaceutical Products , Diagnostic Products , Nutritional Products , Visit Holdingschannel , Abbott Laboratories Daily ,

Creative Planning Sells 54,250 Shares of Abbott Laboratories (NYSE:ABT)

Creative Planning trimmed its position in Abbott Laboratories (NYSE:ABT – Free Report) by 6.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 751,772 shares of the healthcare product maker’s stock after selling 54,250 shares during the quarter. Creative Planning’s holdings in Abbott Laboratories […] ....

United States , Roberte Funck , Lisad Earnhardt , Capital International Investors , Royal Bank , Capital Research Global Investors , Goldman Sachs Group , Manufacturers Life Insurance Company , Norges Bank , Abbott Laboratories , Exchange Commission , Securities Exchange Commission , Creative Planning , Free Report , Research Global Investors , International Investors , Laboratories Stock Down , Get Free Report , Established Pharmaceutical Products , Diagnostic Products , Nutritional Products , Abbott Laboratories Daily ,

Abbott Laboratories (NYSE:ABT) Shares Sold by Mairs & Power Inc.

Mairs & Power Inc. trimmed its position in Abbott Laboratories (NYSE:ABT – Free Report) by 1.0% in the fourth quarter, Holdings Channel reports. The firm owned 1,285,461 shares of the healthcare product maker’s stock after selling 13,538 shares during the quarter. Abbott Laboratories accounts for 1.5% of Mairs & Power Inc.’s holdings, making the stock […] ....

Roberte Funck , Lisad Earnhardt , Alliance Wealth Advisors , Royal Bank , Abbott Laboratories , Renaissance Investment Group , Rappaport Reiches Capital Management , Mairs Power Inc , Berger Financial Group Inc , Holdings Channel , Goldman Sachs Group , Free Report , Wealth Advisors , Reiches Capital Management , Financial Group Inc , Investment Group , Laboratories Stock Down , Get Free Report , Established Pharmaceutical Products , Diagnostic Products , Nutritional Products , Visit Holdingschannel , Abbott Laboratories Daily ,

Abbott Laboratories (NYSE:ABT) Stock Position Trimmed by Bellevue Group AG

Bellevue Group AG lessened its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 1.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,535,656 shares of the healthcare product maker’s stock after selling 25,312 shares during the quarter. Abbott Laboratories accounts […] ....

Lisad Earnhardt , Roberte Funck , Raymond James , Bellevue Group , Wealth Management Group , Securities Exchange Commission , Rise Advisors , Signature Resources Capital Management , Goldman Sachs Group , Abbott Laboratories , Stuart Chaussee Associates Inc , Royal Bank , Free Report , Resources Capital Management , Laboratories Stock Down , Get Free Report , Exchange Commission , Established Pharmaceutical Products , Diagnostic Products , Nutritional Products , Abbott Laboratories Daily ,

Abbott Laboratories (NYSE:ABT) Stock Position Trimmed by Bellevue Group AG

Bellevue Group AG lessened its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 1.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,535,656 shares of the healthcare product maker’s stock after selling 25,312 shares during the quarter. Abbott Laboratories accounts […] ....

Lisad Earnhardt , Raymond James , Roberte Funck , Wealth Management Group , Bellevue Group , Stuart Chaussee Associates Inc , Royal Bank , Signature Resources Capital Management , Abbott Laboratories , Goldman Sachs Group , Rise Advisors , Securities Exchange Commission , Free Report , Resources Capital Management , Laboratories Stock Down , Get Free Report , Exchange Commission , Established Pharmaceutical Products , Diagnostic Products , Nutritional Products , Abbott Laboratories Daily ,